Gault Cheryl

Track

Insider profile

Performance

Overall performance
0.6
Performance over holding periods
0.6
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Gault Cheryl's trades of Rapport Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-01 2026-06-30
PlS Planned sale
82,861 -20.6%
399.13
US$3,657,826 		82,861 -20.6% 399.13 US$3,657,826
2026-07-01 2026-06-30
PlS Planned sale
10,885 +2.2%
200.38
US$2,553,050 		10,885 +2.2% 200.38 US$2,553,050
2026-07-01 2026-06-30
PlS Planned sale
18,753 -48.9%
69.33
US$2,749,619 		18,753 -48.9% 69.33 US$2,749,619
2026-07-01 2026-06-30
PlS Planned sale
1,900 -1.2%
40.09
US$76,174 		1,900 -1.2% 40.09 US$76,174
2026-06-30 2026-06-30
PrS Proposed sale
10,000
40.39
US$403,900 		10,000 40.39 US$403,900
2026-03-31 2026-03-30
PlS Planned sale
2,839 -1.7%
28.55
US$81,062 		2,839 -1.7% 28.55 US$81,062
2026-03-31 2026-03-30
PlS Planned sale
7,161 -4.2%
28.04
US$200,795 		7,161 -4.2% 28.04 US$200,795
2026-03-30 2026-03-30
PrS Proposed sale
10,000
27.84
US$278,400 		10,000 27.84 US$278,400
2026-03-09 2026-03-05
S Sale
2,014 -1.2%
28.93
US$58,265 		2,014 -1.2% 28.93 US$58,265
2026-03-05 2026-03-05
PrS Proposed sale
2,014
28.92
US$58,236 		2,014 28.92 US$58,236
2025-12-01 2025-11-26
PlS Planned sale
5,000 -2.8%
30.10
US$150,486 		5,000 -2.8% 30.10 US$150,486
2025-09-10 2025-09-08
PlS Planned sale
5,000 -2.8%
38.33
US$191,650 		5,000 -2.8% 38.33 US$191,650
2025-09-08 2025-09-08
PrS Proposed sale
10,000
14.36
US$143,600 		10,000 14.36 US$143,600